Digital technology is transforming health care in China, and players including pharmaceutical and medtech companies, distributors and retailers, and payers will need to adapt.
The size and nature of changes and opportunities that digital health care is bringing to stakeholders will vary. Some stakeholders will have the opportunity to digitize existing processes for improved efficiency. Some others face the risk of being cut out of the market altogether. And for others there is an opening to build entirely new digital businesses. But regardless of the specific opportunities or risks, all players have the chance to help shape the market as it undergoes massive change. — Magen Xia
Education
- MBA, Harvard Business School
- Master, management, Shanghai Jiao Tong University
- Bachelor, international trade, Shanghai Jiao Tong University
- Bachelor, automation, Shanghai Jiao Tong University
Magen Xia is a member of the leadership team for Boston Consulting Group's Health Care practice in Greater China, focusing on the fields of health care providers and payers, pharmaceuticals, and medtech. She leads the health care providers sector in China.
Her recent project experience includes helping a prominent insurer’s development in a healthcare industry park focusing on provider businesses, assessing a private general hospital chain business for a global investor, and evaluating the feasibility of cooperation between an investor and an international hospital to jointly establish a new hospital for women and children in South China. She also helped leading companies in the pharmaceutical sector to develop a digital health care strategy and retail channel strategy.
She is the co-author of eight recent BCG health care publications and an active speaker at various health care forums in China.
Before joining BCG, Magen worked at Novartis International in Switzerland.
